Scarica l'app Stockscreener
16.25
5.11%
0.79
Pre-mercato:
15.01
-1.24
-7.63%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVRX Giù?
Forum
Previsione
Precedente Chiudi:
$15.46
Aprire:
$15.29
Volume 24 ore:
260.40K
Relative Volume:
0.99
Capitalizzazione di mercato:
$394.28M
Reddito:
$47.26M
Utile/perdita netta:
$-58.48M
Rapporto P/E:
-6.0076
EPS:
-2.7049
Flusso di cassa netto:
$-40.45M
1 W Prestazione:
-6.18%
1M Prestazione:
+19.13%
6M Prestazione:
+97.45%
1 anno Prestazione:
-33.46%
Intervallo 1D:
$15.29
$16.59
Intervallo di 1 settimana:
$15.29
$17.78
Portata 52W:
$6.40
$25.04
Cvrx Inc Stock (CVRX) Company Profile
Nome
Cvrx Inc
Settore
Industria
Telefono
(763) 416-2850
Indirizzo
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Confronta CVRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
16.25 | 394.28M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
129.10 | 223.92B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.54 | 152.60B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.39 | 149.59B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.97 | 116.65B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.33 | 42.07B | 6.60B | 4.16B | 490.10M | 6.93 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-14 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Reiterato | Lake Street | Buy |
| 2024-05-01 | Ripresa | Craig Hallum | Buy |
| 2024-05-01 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Iniziato | Lake Street | Buy |
| 2022-07-18 | Iniziato | Craig Hallum | Buy |
| 2021-07-26 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-26 | Iniziato | Piper Sandler | Overweight |
| 2021-07-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Cvrx Inc Borsa (CVRX) Ultime notizie
CVRx targets $63M-$65M revenue in 2025 with strengthened sales strategy - MSN
CVRx Announces Strong Revenue Growth in 2024 - TipRanks
Earnings call transcript: CVRx Q4 2024 shows revenue growth, stock dips - MSN
CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
CVRx: Q4 Earnings Snapshot - Leader-Telegram
Earnings Flash (CVRX) CVRX INC. Reports Q4 Revenue $15.3M, vs. FactSet Est of $15.1M - Marketscreener.com
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - The Bakersfield Californian
CVRx Earnings Showcase: Heart Failure Treatment Propels 41% Revenue Explosion in Core Market - StockTitan
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
CVRx Inc (CVRX) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
CVRx, Inc. (NASDAQ:CVRX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
(CVRX) Technical Data - Stock Traders Daily
William Blair upgrades CVRx on stabilization of business - MSN
CVRx Inc (CVRX) Shares Down 4.32% on Jan 24 - GuruFocus.com
Analysts Issue Forecasts for CVRx FY2025 Earnings - Defense World
CVRx, Inc. (NASDAQ:CVRX) Stock Holdings Increased by Barclays PLC - Defense World
Analysts Set Expectations for CVRx FY2025 Earnings - MarketBeat
CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025 - GlobeNewswire
CVRx to Report Q4 2024 Financial Results for Barostim Device on February 4 - StockTitan
CVRx stock price target increased, buy rating on growth acceleration - MSN
CVRx (NASDAQ:CVRX) Reports Strong Financial Results for Q4 and Fiscal Year 2024; Issues 2025 Guidance - Defense World
Craig Hallum Forecasts Strong Price Appreciation for CVRx (NASDAQ:CVRX) Stock - Defense World
Craig Hallum Issues Positive Forecast for CVRx (NASDAQ:CVRX) Stock Price - MarketBeat
Where CVRx Stands With Analysts - Benzinga
CVRx stock price target increased, buy rating on growth acceleration By Investing.com - Investing.com Australia
CVRx (NASDAQ:CVRX) Upgraded at William Blair - Defense World
William Blair Has Bullish Estimate for CVRx FY2024 Earnings - Defense World
CVRx says total Q4 revenue is expected to be between $15.2M and $15.3M - MSN
CVRx (CVRX) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Equities Analysts Set Expectations for CVRx FY2024 Earnings - MarketBeat
CVRx (CVRX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 27% - Simply Wall St
CVRx (CVRX) to Release Earnings on Thursday - Defense World
CVRx upgraded by William Blair to outperform - MSN
(CVRX) On The My Stocks Page - Stock Traders Daily
| MarketBeat - MarketBeat
Jane Street Group LLC Acquires 5,053 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx projects robust revenue growth for Q4 and full year 2024 - Investing.com India
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance - The Manila Times
CVRx Reports Strong Q4 Growth: Revenue Surges 35% as Heart Failure Treatment Demand Accelerates - StockTitan
Barclays PLC Purchases 14,445 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
Geode Capital Management LLC Grows Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World
Cvrx Inc Azioni (CVRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.33%
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):